Leaflet ULTIVA 5mg lyophilisate for solution for injection / infusion


Indicated for: analgesia; anesthesia

Route of administration: injectable / infusion

Substance: remifentanil (opioid analgesic)

ATC: N01AH06 (Nervous system | Anesthetics, general | Opioid anesthetics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression
Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol
Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Remifentanil is an opioid analgesic used to control pain during surgical procedures or other medical interventions. It acts quickly and has a short duration of action, making it ideal for use in general anesthesia.

The medication is administered intravenously under the strict supervision of an anesthesiologist. The dosage is adjusted based on the patient's needs and the duration of the procedure.

Side effects may include respiratory depression, low blood pressure, nausea, or muscle rigidity. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical intervention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory diseases or allergies, to ensure the safe use of remifentanil.

General data about ULTIVA 5mg

  • Substance: remifentanil
  • Date of last drug list: 01-07-2013
  • Commercial code: W41917001
  • Concentration: 5mg
  • Pharmaceutical form: lyophilisate for solution for injection / infusion
  • Quantity: 5
  • Product type: original
  • Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Concentrations available for remifentanil

  • 1mg
  • 2mg
  • 5mg